Orserdu Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

orserdu

stemline therapeutics b.v. - elacestrant - neoplazme dojke - endokrini terapija - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Copiktra Ευρωπαϊκή Ένωση - Σλοβενικά - EMA (European Medicines Agency)

copiktra

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastična sredstva - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Tenzopril HCT 30 mg/12,5 mg filmsko obložene tablete Σλοβενία - Σλοβενικά - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

tenzopril hct 30 mg/12,5 mg filmsko obložene tablete

menarini international o.l.s.a. - hidroklorotiazid; zofenopril - filmsko obložena tableta - hidroklorotiazid 12,5 mg / 1 tableta  zofenopril28,7 mg / 1 tableta; zofenopril 28,7 mg / 1 tableta - zofenopril in diuretiki

Tenzopril HCT 30 mg/12,5 mg filmsko obložene tablete Σλοβενία - Σλοβενικά - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

tenzopril hct 30 mg/12,5 mg filmsko obložene tablete

menarini international o.l.s.a. - hidroklorotiazid; zofenopril - filmsko obložena tableta - hidroklorotiazid 12,5 mg / 1 tableta  zofenopril28,7 mg / 1 tableta; zofenopril 28,7 mg / 1 tableta - zofenopril in diuretiki